Latest News
Lisle, Illinois. February 18, 2020. Seroba’s portfolio company, Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of the first two patients in […]
Boston, Massachusetts & Hamilton, Ontario. February 6, 2020. Seroba’s portfolio company, Fusion Pharmaceuticals Inc., a clinical-stage precision oncology company developing targeted alpha therapeutics, has announced the appointment of Pablo J. Cagnoni, M.D., to the board […]
GALWAY, Ireland. 6 February 2020. Seroba’s portfolio company, Atlantic Therapeutics, a global medical device manufacturer, today announced that the U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive, clinically proven […]
Hamilton, Ontario & Boston, Massachusetts. January 13, 2020. Seroba’s portfolio company, Fusion Pharmaceuticals Inc., a clinical-stage precision oncology company developing next-generation radiopharmaceuticals, today announced an investment commitment of up to US$20 million from Canada Pension Plan […]
Alcester, Warwickshire, UK. 13 January 2020. Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology company that has developed a personal haemodialysis system called SC+, today announced that it has entered […]
Milpitas, California. 6 January 2020. Seroba’s portfolio company, PQ Bypass Inc, a medical device company bringing new advancements to the treatment of peripheral artery disease (PAD), has announced that it has received approval for coverage from […]
